Development of inhibitors against autophagins for cancer therapy

  • Event Date: 2019-02-25
  • Softmatter/Biophys/Others
  • Speaker: Prof. Chih-Wen Shu (ISU)  /  Host: Prof. Lee-Wei Yang (NTHU)
    Place: Lecture Room A of NCTS, 4F, General Building III, NTHU

Biography
Chih-Wen Shu got predoctoral education in National Tsing-Hua University and University of California, San Diego (2001-2007). He further did postdoctoral training in Sanford-Burnham Medical Research Institute (2007-2011). Dr. Shu has expertise in evaluation the role of autophagy in cancer and passion in developing drugs against autophagy modulators as potential targeted therapies. He has performed that autophagy essential protease is a novel therapeutic target in cancer and has screened or designed inhibitors for their use in cancer treatment.
Email: vcwshu@gmail.com orcwshu@isu.edu.tw
 

1/0